Summary
patients treated
Has anyone ever benefited from stem cell?
For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.
FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.
List of patients
| No. | Source | Source type | Diagnosis | Medical sector | Year of application | Therapy | Country | Age of the recipient |
|---|---|---|---|---|---|---|---|---|
| 5601 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 70 |
| 5602 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Germany | 51 |
| 5603 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Germany | 53 |
| 5604 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Germany | 68 |
| 5605 | Apheresis | Allogeneic | Myelodysplastic Syndrome In Fanconi Anemia | Hematology | 2017 | Standard Therapy | Poland | 23 |
| 5606 | Apheresis | Allogeneic | Myelodysplastic Syndrome With Excess Of Blasts | Hematology | 2017 | Standard Therapy | Germany | 62 |
| 5607 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 63 |
| 5608 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 63 |
| 5609 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 66 |
| 5610 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 62 |
| 5611 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 55 |
| 5612 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 62 |
| 5613 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 62 |
| 5614 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 72 |
| 5615 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Germany | 70 |
| 5616 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2017 | Standard Therapy | Poland | 47 |
| 5617 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2017 | Standard Therapy | Poland | 44 |
| 5618 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2017 | Standard Therapy | Poland | 56 |
| 5619 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2017 | Standard Therapy | Poland | 57 |
| 5620 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2017 | Standard Therapy | Poland | 38 |
| 5621 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2017 | Standard Therapy | Poland | 7 |
| 5622 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2017 | Standard Therapy | Germany | 37 |
| 5623 | Apheresis | Allogeneic | Niemann–Pick Disease | Hematology | 2017 | Standard Therapy | Poland | 2 |
| 5624 | Apheresis | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 36 |
| 5625 | Apheresis | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 58 |
| 5626 | Apheresis | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 53 |
| 5627 | Apheresis | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 1 |
| 5628 | Apheresis | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 55 |
| 5629 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 63 |
| 5630 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 56 |
| 5631 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 47 |
| 5632 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 57 |
| 5633 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 65 |
| 5634 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 58 |
| 5635 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 42 |
| 5636 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 36 |
| 5637 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 63 |
| 5638 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 68 |
| 5639 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 52 |
| 5640 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 53 |
| 5641 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 56 |
| 5642 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 65 |
| 5643 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 55 |
| 5644 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 69 |
| 5645 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 69 |
| 5646 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 72 |
| 5647 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 51 |
| 5648 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 57 |
| 5649 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2017 | Standard Therapy | Germany | 52 |
| 5650 | Apheresis | Allogeneic | Osteopetrosis | Metabolic | 2017 | Standard Therapy | Poland | 3 |
| 5651 | Apheresis | Allogeneic | Other Malignancy | Hematology | 2017 | Standard Therapy | Poland | 59 |
| 5652 | Apheresis | Allogeneic | Other Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 71 |
| 5653 | Apheresis | Allogeneic | Post–Polycythemia Vera Myelofibrosis | Hematology | 2017 | Standard Therapy | Germany | 61 |
| 5654 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 51 |
| 5655 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 66 |
| 5656 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 50 |
| 5657 | Apheresis | Allogeneic | Primary Immunodeficiency | Hematology | 2017 | Standard Therapy | Poland | 4 |
| 5658 | Apheresis | Allogeneic | Primary Immunodeficiency | Hematology | 2017 | Standard Therapy | Poland | 2 |
| 5659 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 29 |
| 5660 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 32 |
| 5661 | Apheresis | Allogeneic | Prolymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 38 |
| 5662 | Apheresis | Allogeneic | Prolymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 63 |
| 5663 | Apheresis | Allogeneic | Richter's Transformation At Chronic Lymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Germany | 60 |
| 5664 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 24 |
| 5665 | Apheresis | Allogeneic | Secondary Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Germany | 61 |
| 5666 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2017 | Standard Therapy | Poland | 14 |
| 5667 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2017 | Standard Therapy | Poland | 27 |
| 5668 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2017 | Standard Therapy | Poland | 32 |
| 5669 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2017 | Standard Therapy | Poland | 16 |
| 5670 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 30 |
| 5671 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 7 |
| 5672 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 25 |
| 5673 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 28 |
| 5674 | Apheresis | Allogeneic | T-Cell Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Germany | 24 |
| 5675 | Apheresis | Allogeneic | T-Cell Lymphoblastic Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 19 |
| 5676 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 56 |
| 5677 | Apheresis | Autologous | T-Cell-Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 63 |
| 5678 | Apheresis | Allogeneic | Β – Thalassemia Major | Hematology | 2017 | Standard Therapy | Poland | 4 |
| 5679 | Cord Tissue | Allogeneic – Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 22 |
| 5680 | Cord Tissue | Allogeneic – Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 32,3 |
| 5681 | Cord Tissue | Allogeneic – Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 44,7 |
| 5682 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2016 | Experimental Therapy | Poland | 14 |
| 5683 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2016 | Experimental Therapy | Poland | 6 |
| 5684 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2016 | Experimental Therapy | Poland | 60,5 |
| 5685 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2016 | Experimental Therapy | Poland | 3,11 |
| 5686 | Cord Tissue | Allogeneic – Unrelated | Adrenoleukodystrophy | Neurology | 2016 | Experimental Therapy | Poland | 11,11 |
| 5687 | Cord Tissue | Allogeneic – Unrelated | Adrenoleukodystrophy | Neurology | 2016 | Experimental Therapy | Poland | 6,11 |
| 5688 | Cord Tissue | Allogeneic – Unrelated | Adrenoleukodystrophy | Neurology | 2016 | Experimental Therapy | Poland | 9,7 |
| 5689 | Cord Tissue | Allogeneic – Unrelated | Adrenoleukodystrophy; Encephalopathy | Neurology | 2016 | Experimental Therapy | Poland | 8,4 |
| 5690 | Cord Tissue | Allogeneic – Unrelated | Age-Related Macular Degeneration | Ophthalmology | 2016 | Experimental Therapy | Poland | 86,5 |
| 5691 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 44,5 |
| 5692 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 60,8 |
| 5693 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 32,2 |
| 5694 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 53,7 |
| 5695 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 59,4 |
| 5696 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 33,4 |
| 5697 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 37,4 |
| 5698 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 39,3 |
| 5699 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 63,2 |
| 5700 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 54,11 |